Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

153

Participants

Timeline

Start Date

October 1, 2007

Primary Completion Date

March 29, 2011

Study Completion Date

April 26, 2011

Conditions

Head and Neck CancerSquamous Cell Carcinoma

Interventions

DRUG

Cisplatin

Administered intravenously (IV; in a vein)

RADIATION

Standard Fractionation Radiotherapy

70 Gy administered in 2 Gy fractions daily for 5 days a week for 7 weeks (35 fractions)

DRUG

Panitumumab

Administered intravenously